Insilico Medicine
by Insilico Medicine · paid · Last verified 2026-03-17
Insilico Medicine is an AI-driven drug discovery company that has become the first to advance an AI-designed small molecule into Phase II clinical trials, demonstrating end-to-end AI-powered drug development from target identification through IND. Its Chemistry42 and PandaOmics platforms generatively design and screen drug candidates.
https://insilico.com ↗C
C—Below Average
Adoption: DQuality: AFreshness: ACitations: B+Engagement: F
Specifications
- License
- Proprietary
- Pricing
- paid
- Capabilities
- generative-drug-design, target-identification, molecular-generation, clinical-prediction
- Integrations
- Use Cases
- drug-discovery, target-identification, medicinal-chemistry, clinical-trials
- API Available
- No
- Tags
- drug-discovery, ai-chemistry, generative-ai, biotech, startup
- Added
- 2026-03-17
- Completeness
- 100%
Index Score
46Adoption
28
Quality
84
Freshness
80
Citations
72
Engagement
0
Put AI to work for your business
Deploy this provider alongside autonomous AaaS agents that handle tasks end-to-end — no babysitting required.